Revvity, 3301-001U, GSP Neonatal hTSH kit

Overview
Congenital hypothyroidism (CH) results from a failure of the thyroid glands to produce thyroid hormones in adequate amounts. The condition can easily be treated with daily doses of thyroid hormones but clinical diagnosis is difficult to establish and the disease may continue unrecognized for a long time causing irreversible brain damage. However, increased thyroid stimulating hormone (hTSH) and decreased thyroxine are clear signs of CH, which have led to the establishment of large scale screening programs.
GSP Neonatal hTSH assay:

The incubation time is only 3.5 h
Sensitive, robust DELFIA chemistry for confidence in results
All reagents are ready to use
The kit contains reagents and plates for 1152 tests (12 plates)

The assay is based on a direct sandwich technique where two monoclonal antibodies recognize separate antigenic determinants on the hTSH molecule. The fluorescence signal is proportional to the analyte concentration in the sample.
Features/Benefits:

The incubation time is only 3.5 h/li>
Sensitive, robust DELFIA chemistry for confidence in results/li>
All reagents are ready to use/li>
The kit contains reagents and plates for 1152 tests (12 plates) Application-Newborn Screening
Brand-GSP®
Detection Modality-Time-Resolved Fluorescence (TRF)
Disorders-Congenital Hypothyroidism
Instrument Compatibility-GSP
Quantity-1152 tests
Sample Type-Dried blood spots
Technology-DELFIA
Unit Size-1 kit